Ahmad Imran, Iwata Tomoko, Leung Hing Y
Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, UK.
Biochim Biophys Acta. 2012 Apr;1823(4):850-60. doi: 10.1016/j.bbamcr.2012.01.004. Epub 2012 Jan 18.
In this review, the evidence for a role of fibroblast growth factor receptor (FGFR) mediated signalling in carcinogenesis are considered and relevant underlying mechanisms highlighted. FGF signalling mediated by FGFR follows a classic receptor tyrosine kinase signalling pathway and its deregulation at various points of its cascade could result in malignancy. Here we review the accumulating reports that revealed the association of FGF/FGFRs to various types of cancer at a genetic level, along with in vitro and in vivo evidences available so far, which indicates the functional involvement of FGF signalling in tumour formation and progression. An increasing number of drugs against the FGF pathways is currently in clinical testing. We will discuss the strategies for future FGF research in cancer and translational approaches.
在本综述中,我们探讨了成纤维细胞生长因子受体(FGFR)介导的信号传导在致癌作用中的证据,并强调了相关的潜在机制。由FGFR介导的FGF信号遵循经典的受体酪氨酸激酶信号通路,其级联反应在各个环节的失调都可能导致恶性肿瘤的发生。在这里,我们回顾了越来越多的报告,这些报告揭示了FGF/FGFRs在基因水平上与各种类型癌症的关联,以及目前可用的体外和体内证据,这表明FGF信号在肿瘤形成和进展中发挥了功能作用。目前越来越多针对FGF通路的药物正在进行临床试验。我们将讨论未来癌症中FGF研究的策略和转化方法。